Clinical heterogeneity in autoimmune acute liver failure

World Journal of Gastroenterology

Volumn 13, Issue 12, 2007, Pages 1824-1827

  Chavez Tapia, Norberto Carlos ^a   MartinezSalgado, Julio ^a   Granados, Julio ^a   Uribe, Misael ^a   Tellez Avila, Felix I ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Acute liver failure; Autoimmune hepatitis; Corticosteroids

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AZATHIOPRINE; BILIRUBIN; CREATININE; HYDROCORTISONE; METHYLPREDNISOLONE; PREDNISONE;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; AUTOIMMUNE HEPATITIS; BILIRUBIN BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER BIOPSY; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEXICO; MORTALITY; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 34248204563     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i12.1824     Document Type: Article

References (19)

1. O'Grady JG. Acute liver failure. Postgrad Med J 2005; 81: 148-154
2. Bernal W. Changing patterns of causation and the use of transplantation in the United kingdom. Semin Liver Dis 2003; 23: 227-237
3. O'Grady JG. Acute Liver Failure. In: Comprehensive clinical hepatology. O'Grady JG, Lake JR, Howdle PD, editors. London: Mosby, 2000:1-20
4. Squires RH Jr. Autoimmune hepatitis in children. Curr Gastroenterol Rep 2004; 6: 225-230
5. Tessier G, Villeneuve E, Villeneuve JP. Etiology and outcome of acute liver failure: experience from a liver transplantation centre in Montreal. Can J Gastroenterol 2002; 16: 672-676
6. Schiodt FV, Atillasoy E, Shakil AO, Schiff ER, Caldwell C, Kowdley KV, Stribling R, Crippin JS, Flamm S, Somberg KA, Rosen H, McCashland TM, Hay JE, Lee WM. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg 1999; 5: 29-34
7. Miyake Y, Iwasaki Y, Terada R, Onishi T, Okamoto R, Sakai N, Sakaguchi K, Shiratori Y. Clinical characteristics of fulminant-type autoimmune hepatitis: an analysis of eleven cases. Aliment Pharmacol Ther 2006; 23: 1347-1353
8. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, Cooksley WG, Czaja AJ, Desmet VJ, Donaldson PT, Eddleston AL, Fainboim L, Heathcote J, Homberg JC, Hoofnagle JH, Kakumu S, Krawitt EL, Mackay IR, MacSween RN, Maddrey WC, Manns MP, McFarlane IG, Meyer zum Buschenfelde KH, Zeniya M. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-938
9. Trey C, Davidson CS. The management of fulminant hepatic failure. In: Progress in Liver Disease. Popper H, Schaffner F, editors. New York: Grune & Stratton, 1970: 282-298
10. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-829
11. Nystrom PO. The systemic inflammatory response syndrome: definitions and aetiology. J Antimicrob Chemother 1998; 41 Suppl A: 1-7
12. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250-1256
13. Barshes NR, Lee TC, Balkrishnan R, Karpen SJ, Carter BA, Goss JA. Risk stratification of adult patients undergoing orthotopic liver transplantation for fulminant hepatic failure. Transplantation 2006; 81: 195-201
14. Gimson AE, O'Grady J, Ede RJ, Portmann B, Williams R. Late onset hepatic failure: clinical, serological and histological features. Hepatology 1986; 6: 288-294
15. Pelaez-Luna M, Martinez-Salgado J, Olivera-Martinez MA. Utility of the MAYO End-Stage Liver Disease score, King's College Criteria, and a new in-hospital mortality score in the prognosis of in-hospital mortality in acute liver failure. Transplant Proc 2006; 38: 927-929
16. Viruet EJ, Torres EA. Steroid therapy in fulminant hepatic failure secondary to autoimmune hepatitis. P R Health Sci J 1998; 17: 297-300
17. Ohnishi K, Torimoto Y, Ohhira M, Yasuda A, Matsumoto A, Murazurni Y, Mizuno M, Murazumi K, Ohta H, Kohda. H. Nippon Shokakibyo Gakkai Zasshi 1994; 91: 1457-1463
18. KKessler WR, Cummings OW, Eckert G, Chalasani N, Lumeng L, Kwo PY. Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. Clin Gastroenterol Hepatol 2004; 2: 625-631
19. Harry R, Auzinger G, Wendon J. The effects of supraphysiological doses of corticosteroids in hypotensive liver failure. Liver Int 2003; 23: 71-77